A committee of MPs has highlighted the impact and unprecedented challenge caused by COVID-19 to the provision of essential services.
More than 10 percent of young and healthy people who develop severe COVID-19 have misguided antibodies that attack not the virus, but the immune system itself, new research shows. Another 3.5 percent, at least, carry a specific genetic mutation.
Short-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients with COVID-19 who are risk assessed prior to receiving the drug.
Research presented at the ESCMID Conference on Coronavirus Disease has investigated the accuracy of a number of antibody assays.
A 90-minute COVID-19 test has been shown to have over 94 per cent sensitivity, and 100 per cent specificity in a new study.
Speaking at the All-Party Parliamentary Group (APPG) on Coronavirus, RCN director of nursing, policy and public affairs, Susan Masters, called for an inquiry to investigate how the UK prepared for and responded to the pandemic.
A £500 million funding package is being invested in next generation testing technology and increased testing capacity, the Health and Social Care Secretary has announced.
Up to 200 staff working for Queen Victoria Hospital are being recruited to take part in a major national study to help scientists to find out more about COVID-19 antibodies and whether having COVID-19 antibodies makes someone immune to the virus.
A Medical Technology Group survey shows that patients are embracing technology during the COVID-19 pandemic, but still value real-life consultations.
The University of Kent's School of Biosciences and the Institute of Medical Virology at Goethe-University, Frankfurt am Main, have identified that a glycoprotein known as transferrin may critically contribute to severe forms of COVID-19.
A new post-mortem study of patients who have died from COVID-19 found severe damage to the lungs and signs of blood clotting in major organs.
Ecolab has been asked to supply NHS Supply Chain with five million litres of hand sanitiser by the end of the year, to meet increased demand in the wake of COVID-19.
Thousands of patients with cancer have had chemotherapy delivered to their doors so that they can more safely receive treatment during the coronavirus pandemic.
The ONS COVID-19 Infection Survey tracking the virus in the general population will be expanded from regularly testing 28,000 people per fortnight in England to 150,000 by October, the Health Secretary has announced.
Wolters Kluwer Health has won seven new NHS contracts for its clinical decision support tool UpToDate, as hospitals have turned to evidence-based support during the COVID-19 crisis.
More than 100,000 people across England have tested themselves for SARS-CoV-2 antibodies at home as part of a major research programme.